In our Early Stage Islet we engage in high-risk, early-stage investments, diversifying our portfolio to mitigate risks associated with binary outcomes.

Advancing radiotherapeutics to treat solid tumors.

Elypta+logo+Standard@4x.png

Advancing Cancer Detection.

Personlised Cancer Theraphy that boosts tumour-specific responses of the immune system.

saga-logo.png

Ultrasensitive cancer diagnostics & monitoring.

spago-logo-1024.png

Precision Nanomedicine for Improved Diagnosis and Treatment.